NM_005201.4:c.169A>G

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_005201.4(CCR8):​c.169A>G​(p.Ile57Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)

Consequence

CCR8
NM_005201.4 missense

Scores

18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.493

Publications

0 publications found
Variant links:
Genes affected
CCR8 (HGNC:1609): (C-C motif chemokine receptor 8) This gene encodes a member of the beta chemokine receptor family, which is predicted to be a seven transmembrane protein similar to G protein-coupled receptors. Chemokines and their receptors are important for the migration of various cell types into the inflammatory sites. This receptor protein preferentially expresses in the thymus. I-309, thymus activation-regulated cytokine (TARC) and macrophage inflammatory protein-1 beta (MIP-1 beta) have been identified as ligands of this receptor. Studies of this receptor and its ligands suggested its role in regulation of monocyte chemotaxis and thymic cell apoptosis. More specifically, this receptor may contribute to the proper positioning of activated T cells within the antigenic challenge sites and specialized areas of lymphoid tissues. This gene is located at the chemokine receptor gene cluster region. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.07548082).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005201.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CCR8
NM_005201.4
MANE Select
c.169A>Gp.Ile57Val
missense
Exon 2 of 2NP_005192.1P51685-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CCR8
ENST00000326306.5
TSL:1 MANE Select
c.169A>Gp.Ile57Val
missense
Exon 2 of 2ENSP00000326432.4P51685-1
CCR8
ENST00000414803.2
TSL:1
c.100+69A>G
intron
N/AENSP00000390104.1C9JIP9
ENSG00000287780
ENST00000655387.2
n.435-39550T>C
intron
N/A

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
33
GnomAD4 genome
Cov.:
32

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.067
T
BayesDel_noAF
Benign
-0.33
CADD
Benign
12
DANN
Benign
0.87
DEOGEN2
Benign
0.028
T
Eigen
Benign
-0.61
Eigen_PC
Benign
-0.52
FATHMM_MKL
Benign
0.33
N
LIST_S2
Benign
0.63
T
M_CAP
Benign
0.012
T
MetaRNN
Benign
0.075
T
MetaSVM
Benign
-0.88
T
MutationAssessor
Benign
1.0
L
PhyloP100
-0.49
PrimateAI
Benign
0.47
T
PROVEAN
Benign
0.11
N
REVEL
Benign
0.20
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.41
B
Vest4
0.20
MutPred
0.53
Gain of catalytic residue at I57 (P = 0.0205)
MVP
0.60
MPC
0.16
ClinPred
0.19
T
GERP RS
3.8
Varity_R
0.037
gMVP
0.030
Mutation Taster
=84/16
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

hg19: chr3-39373991; API